124 related articles for article (PubMed ID: 9866157)
1. [Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders].
Golimbet VE; Aksenova MG; Abramova LI; Kaleda VG; Orlova VA; Braga EA; Nosikov VV; Trubnikov VI
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(12):32-5. PubMed ID: 9866157
[TBL] [Abstract][Full Text] [Related]
2. [Dopamine receptor gene (DRD2) polymorphism in patients with endogenous psychoses with regard to their clinical heterogeneity].
Golimbet VE; Aksenova MG; Abramova LI; Kaleda VG; Orlova VA; Brusentseva LN; Nosikov VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):50-3. PubMed ID: 11765615
[TBL] [Abstract][Full Text] [Related]
3. [Serotonin receptor gene allele polymorphism (5HTR2A) and clinical pathogenetic characteristics in patients with schizophrenia and schizophrenia spectrum disorders].
Golimbet VE; Manandian KK; Abramova LI; Orlova VA; Kaleda VG; Oleĭchik IV; Iurov IuB; Trubnikov VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(2):36-9. PubMed ID: 10709289
[TBL] [Abstract][Full Text] [Related]
4. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls.
Weiss J; Mägert HJ; Cieslak A; Forssmann WG
Eur J Med Res; 1996 Jun; 1(9):439-45. PubMed ID: 9353244
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptor Taq IA polymorphism is associated with postoperative nausea and vomiting.
Nakagawa M; Kuri M; Kambara N; Tanigami H; Tanaka H; Kishi Y; Hamajima N
J Anesth; 2008; 22(4):397-403. PubMed ID: 19011779
[TBL] [Abstract][Full Text] [Related]
6. Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.
Kwon JS; Kim E; Kang DH; Choi JS; Yu KS; Jang IJ; Shin SG;
Eur Neuropsychopharmacol; 2008 Dec; 18(12):897-907. PubMed ID: 18786813
[TBL] [Abstract][Full Text] [Related]
7. Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.
Stöber G; Jatzke S; Heils A; Jungkunz G; Knapp M; Mössner R; Riederer P; Lesch KP
J Neural Transm (Vienna); 1998; 105(1):101-9. PubMed ID: 9588764
[TBL] [Abstract][Full Text] [Related]
8. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia.
Lee HS; Kim SH; Lee HJ; Kim L; Lee SK; Jang DW; Lee MS; Son BG; Suh KY; Kim S
Am J Med Genet; 2002 Aug; 114(6):593-7. PubMed ID: 12210271
[TBL] [Abstract][Full Text] [Related]
10. Alcohol-related expectancies are associated with the D2 dopamine receptor and GABAA receptor beta3 subunit genes.
Young RM; Lawford BR; Feeney GF; Ritchie T; Noble EP
Psychiatry Res; 2004 Jul; 127(3):171-83. PubMed ID: 15296817
[TBL] [Abstract][Full Text] [Related]
11. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
Mihara K; Kondo T; Suzuki A; Yasui N; Nagashima U; Ono S; Otani K; Kaneko S
Psychopharmacology (Berl); 2000 Apr; 149(3):246-50. PubMed ID: 10823405
[TBL] [Abstract][Full Text] [Related]
12. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population.
Behravan J; Hemayatkar M; Toufani H; Abdollahian E
Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314
[TBL] [Abstract][Full Text] [Related]
13. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
Kurylev AA; Brodyansky VM; Andreev BV; Kibitov AO; Limankin OV; Mosolov SN
Psychiatr Danub; 2018 Jun; 30(2):157-163. PubMed ID: 29930225
[TBL] [Abstract][Full Text] [Related]
14. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders.
Arinami T; Itokawa M; Aoki J; Shibuya H; Ookubo Y; Iwawaki A; Ota K; Shimizu H; Hamaguchi H; Toru M
Am J Med Genet; 1996 Apr; 67(2):133-8. PubMed ID: 8723039
[TBL] [Abstract][Full Text] [Related]
15. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia.
Lawford BR; Young RM; Swagell CD; Barnes M; Burton SC; Ward WK; Heslop KR; Shadforth S; van Daal A; Morris CP
Schizophr Res; 2005 Feb; 73(1):31-7. PubMed ID: 15567074
[TBL] [Abstract][Full Text] [Related]
16. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
Itokawa M; Arinami T; Futamura N; Hamaguchi H; Toru M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1369-75. PubMed ID: 7902708
[TBL] [Abstract][Full Text] [Related]
17. Association study between the Taq1A (rs1800497) polymorphism and schizophrenia in a Brazilian sample.
Cordeiro Q; Vallada H
Arq Neuropsiquiatr; 2014 Aug; 72(8):582-6. PubMed ID: 25098474
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
19. Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism.
Madrid GA; MacMurray J; Lee JW; Anderson BA; Comings DE
Alcohol; 2001 Feb; 23(2):117-22. PubMed ID: 11331109
[TBL] [Abstract][Full Text] [Related]
20. [Lack of association between 141C Ins/Del promoter polymorphism of DRD2 gene and schizophrenia].
Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Hauser J
Psychiatr Pol; 2002; 36(3):413-9. PubMed ID: 12149917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
